ID2 Inhibits Bladder Cancer Progression and Metastasis via PI3K/AKT Signaling Pathway
Open Access
- 22 October 2021
- journal article
- research article
- Published by Frontiers Media SA in Frontiers in Cell and Developmental Biology
Abstract
Background: Inhibitors of DNA-binding (ID) proteins are important regulators of cell proliferation and differentiation. The aim of this study was to evaluated the role of ID proteins in bladder cancer (BCa) and related molecular mechanisms. Methods: The TCGA database was analyzed for the expression and clinical significance of ID proteins. The expression of ID2 was determined by qRT-PCR, immunohistochemical staining and western blot. The role of ID2 was determined by CCK-8, colony formation, wound healing, transwell and xenograft tumor assays, and the potential mechanism of ID2 in BCa was investigated by RNA sequencing. Results: ID2 expression was significantly downregulated in TCGA database and clinical samples, and high ID2 expression was associated with low-grade tumor staging and correlated with better overall survival, disease specific survival (DSS) and progress free interval (PFI). In vivo and in vitro experiments showed that knockdown of ID2 promoted proliferation, migration, invasion and metastasis of BCa cells, while overexpression of ID2 significantly inhibited cell proliferation, migration, invasion and metastasis. Mechanistically, ID2 acts as a tumor suppressor through PI3K/AKT signaling pathway to inhibit the progression and metastasis of BCa. Conclusion: Our results suggest that ID2 exerts tumor suppressive effects in BCa through PI3K/AKT signaling pathway, and altered ID2 expression can be used as a biomarker of BCa progression and metastasis.This publication has 30 references indexed in Scilit:
- Curcumin alters gene expression-associated DNA damage, cell cycle, cell survival and cell migration and invasion in NCI-H460 human lung cancer cells in vitroOncology Reports, 2015
- Bladder Tumor Heterogeneity: The Impact on Clinical TreatmentUrologia Internationalis, 2015
- Upregulated H19 contributes to bladder cancer cell proliferation by regulating ID2 expressionThe FEBS Journal, 2013
- The Intracellular Localization of ID2 Expression Has a Predictive Value in Non Small Cell Lung CancerPLOS ONE, 2009
- Therapeutic targeting of Id2 reduces growth of human colorectal carcinoma in the murine liverOncogene, 2008
- Id-1 and Id-2 are markers for metastasis and prognosis in oesophageal squamous cell carcinomaBritish Journal of Cancer, 2007
- Id family of helix-loop-helix proteins in cancerNature Reviews Cancer, 2005
- High ID2 protein expression correlates with a favourable prognosis in patients with primary breast cancer and reduces cellular invasiveness of breast cancer cellsInternational Journal of Cancer, 2005
- Id genes and proteins as promising targets in cancer therapyTrends in Molecular Medicine, 2004
- The protein Id: A negative regulator of helix-loop-helix DNA binding proteinsCell, 1990